Bio Non Current Assets Total from 2010 to 2025

TECH Stock  USD 64.92  0.57  0.87%   
Bio Techne's Non Current Assets Total are increasing with slightly volatile movements from year to year. Non Current Assets Total are estimated to finish at about 2.5 B this year. Non Current Assets Total is the total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets. View All Fundamentals
 
Non Current Assets Total  
First Reported
1989-09-30
Previous Quarter
2.1 B
Current Value
B
Quarterly Volatility
662.5 M
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Bio Techne financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bio Techne's main balance sheet or income statement drivers, such as Depreciation And Amortization of 134.9 M, Total Revenue of 1.4 B or Gross Profit of 929.4 M, as well as many indicators such as Price To Sales Ratio of 6.9, Dividend Yield of 0.0049 or PTB Ratio of 6.78. Bio financial statements analysis is a perfect complement when working with Bio Techne Valuation or Volatility modules.
  
Check out the analysis of Bio Techne Correlation against competitors.

Latest Bio Techne's Non Current Assets Total Growth Pattern

Below is the plot of the Non Current Assets Total of Bio Techne Corp over the last few years. It is the total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets. Bio Techne's Non Current Assets Total historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bio Techne's overall financial position and show how it may be relating to other accounts over time.
Non Current Assets Total10 Years Trend
Slightly volatile
   Non Current Assets Total   
1.5B1.8B1.7B2.0B2.1B2.4B2.5B16%-4%19%3%15%5%100%
       Timeline  

Bio Non Current Assets Total Regression Statistics

Arithmetic Mean1,292,170,760
Geometric Mean736,254,372
Coefficient Of Variation59.70
Mean Deviation638,145,635
Median1,471,803,000
Standard Deviation771,478,582
Sample Variance595179.2T
Range2.5B
R-Value0.99
Mean Square Error10205T
R-Squared0.98
Slope160,741,097
Total Sum of Squares8927688T

Bio Non Current Assets Total History

20252.5 B
20242.4 B
20232.1 B
2022B
20211.7 B
20201.8 B
20191.5 B

About Bio Techne Financial Statements

Investors use fundamental indicators, such as Bio Techne's Non Current Assets Total, to determine how well the company is positioned to perform in the future. Although Bio Techne's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Non Current Assets Total2.4 B2.5 B

Currently Active Assets on Macroaxis

When determining whether Bio Techne Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bio Techne's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Techne Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Techne Corp Stock:
Check out the analysis of Bio Techne Correlation against competitors.
You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bio Techne. If investors know Bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bio Techne listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.294
Dividend Share
0.32
Earnings Share
0.98
Revenue Per Share
7.568
Quarterly Revenue Growth
0.09
The market value of Bio Techne Corp is measured differently than its book value, which is the value of Bio that is recorded on the company's balance sheet. Investors also form their own opinion of Bio Techne's value that differs from its market value or its book value, called intrinsic value, which is Bio Techne's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bio Techne's market value can be influenced by many factors that don't directly affect Bio Techne's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bio Techne's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Techne is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio Techne's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Discover investing ideas

Utilize additional investing modules

News Freq…Investor S…100%